Galapagos NV
GLPG
#4871
Rank
ยฃ1.42 B
Marketcap
ยฃ21.27
Share price
-1.58%
Change (1 day)
11.18%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -ยฃ0.4 Billion

According to Galapagos NV's latest financial reports the company's current earnings are ยฃ0.32 Billion. In 2024 the company made an earning of -ยฃ4.29 Million, an increase over its 2023 earnings that were of -ยฃ24.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.4 Billion9188.51%
2024 -ยฃ4.29 Million-82.77%
2023 -ยฃ24.89 Million-85.59%
2022 -ยฃ0.18 Billion60.71%
2021 -ยฃ0.11 Billion-60.08%
2020 -ยฃ0.27 Billion-331.44%
2019 ยฃ0.11 B-523.76%
2018 -ยฃ27.45 Million-72.34%
2017 -ยฃ99.25 Million-329.59%
2016 ยฃ43.22 M-144.3%
2015 -ยฃ97.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.88 B-6,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.27 B-1,690.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ4.89 B-1,339.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.71 B-1,546.16%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ16.63 B-4,311.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.46 B-2,749.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ7.34 B-1,958.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-ยฃ39.67 Million-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.59 B-504.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel